No, mupirocin ointment should not be used in the ears
Mupirocin ointment is explicitly contraindicated for otic (ear) use according to FDA labeling, which states it is "not for intranasal, ophthalmic, or other mucosal use" and specifically warns against mucosal application 1. The ear canal contains mucosal surfaces where this formulation is not appropriate.
Why Mupirocin Ointment Is Inappropriate for Ears
The FDA drug label clearly specifies that mupirocin ointment is:
- For topical skin use only - intended for application to intact skin with cotton swab or gauze pad 1
- Not formulated for mucosal surfaces - the ointment base and polyethylene glycol vehicle are designed for skin, not mucous membranes 1
- Risk of polyethylene glycol absorption - particularly problematic in the ear canal where absorption could occur, especially with renal impairment 1
What to Use Instead for Ear Infections
For acute otitis externa (swimmer's ear), the 2014 AAO-HNS guidelines strongly recommend 2:
- Topical antimicrobial ear drops as first-line therapy (not ointments)
- Specifically formulated otic preparations that are:
- Non-ototoxic if tympanic membrane perforation is present or suspected
- Designed for ear canal delivery
- Achieve 100-1000x higher concentrations than systemic therapy
Avoid systemic antibiotics as initial therapy unless there is extension beyond the ear canal 2
Special Circumstance: Tympanostomy Tubes
While research shows mupirocin ointment has been studied off-label for MRSA infections in patients with tympanostomy tubes 3, 4, 5, this represents:
- Specialized use in refractory MRSA cases
- Application by trained otolaryngologists
- Not routine or FDA-approved practice
- Animal studies show potential high-frequency hearing threshold elevations 6
The research evidence for mupirocin in tube otorrhea does not override the FDA contraindication for routine use - these were investigational applications for resistant organisms when standard otic drops failed.
Key Clinical Pitfall
Do not confuse mupirocin's effectiveness against Staphylococcus aureus (including MRSA) with appropriateness for ear use. The ointment formulation, polyethylene glycol base, and lack of otic-specific formulation make it unsuitable despite antimicrobial activity.
Use FDA-approved otic drops for ear infections. Reserve mupirocin ointment for its approved indication: topical skin infections.